Physician profile
Michael K Floyd
NPI 1861445280
$11,406.66
in general payments reported to CMS, 2019-2025
54 companies · $2,583 in 2025
The $2,583 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,125 · 2020: $908 · 2021: $1,460 · 2022: $991 · 2023: $1,707 · 2024: $1,633 · 2025: $2,583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,790 · Education: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,789.97 |
| Education | $132.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,794.31 | 2019-2025 | Tactra, General - Erectile Dysfunction, Ams 700 |
| Abbvie INC. | $1,644.85 | 2019-2025 | |
| Janssen Biotech, INC. | $1,082.19 | 2019-2025 | Erleada, Akeega, Balversa |
| Pfizer INC. | $1,036.70 | 2019-2025 | |
| Astellas Pharma US INC | $771.89 | 2019-2025 | Xtandi |
| Sumitomo Pharma America, INC. | $534.83 | 2023-2025 | Orgovyx, Gemtesa |
| Ferring Pharmaceuticals INC. | $457.25 | 2019-2025 | Adstiladrin |
| Allergan, INC. | $390.29 | 2019-2022 | |
| Urogen Pharma, INC. | $320.14 | 2021-2025 | |
| Dendreon Pharmaceuticals LLC | $297.13 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $280.69 | 2019-2025 | |
| Myovant Sciences INC. | $199.88 | 2021-2022 | |
| Blue Earth Diagnostics | $195.80 | 2020-2024 | |
| Endo Pharmaceuticals INC. | $178.41 | 2019-2023 | Xiaflex, Aveed |
| Merck Sharp & Dohme LLC | $160.89 | 2020-2025 | Lynparza, Keytruda |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Floyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.